We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

DiaSys Highlights Wide Range of Reagents and Instrumentation Products

By LabMedica International staff writers
Posted on 25 Jul 2023

DiaSys Diagnostic Systems (Holzheim, Germany) is presenting its products at AACC 2023 with a booth to support visitors in finding the right tools and services to meet the growing needs of their lab. DiaSys is offering a closer look into its comprehensive portfolio of clinical chemistry analyzers, reagents, calibrators, and controls, and is also presenting a scientific poster on procalcitonin.

Serum procalcitonin (PCT) levels represent a sensitive marker for severe and systemic bacterial infections. PCT is primarily produced in thyroid C cells as a precursor of calcitonin but is expressed in nearly all tissues by stimulation of interleukins and bacterial endotoxins. In healthy individuals, PCT concentrations are usually below 0.05 ng/mL, and a significant increase of PCT up to a thousand-fold appears within a few hours in patients with severe and systemic bacterial infections. DiaSys Procalcitonin FS is a fluid-stable, particle-enhanced immunoturbidimetric assay with outstanding onboard and calibration stability, providing a convenient workflow on clinical chemistry analyzers. Procalcitonin FS determination in serum and plasma within the measuring range of 0.2 ng/mL to 50 ng/mL can be performed with high precision at clinical cut-off levels for sepsis. The performance is complemented by high tolerance to endogenous interferents and various therapeutics used in sepsis management. Procalcitonin FS shows a good correlation to established methods. Results from ring trials and a publication demonstrate the strengths of the assay.


Image: DiaSys is presenting a scientific poster on procalcitonin at AACC 2023 (Photo courtesy of DiaSys)
Image: DiaSys is presenting a scientific poster on procalcitonin at AACC 2023 (Photo courtesy of DiaSys)

Among its other products being highlighted at the show is the DiaSys CRP FS liquid-stable immunoturbidimetric test with dedicated ready-to-use calibrators and controls that allow true differentiation of borderline cases. DiaSys has recently extended its cardiovascular risk assessment portfolio with two innovative new reagents, HDL-c direct FS and LDL-c direct FS. Both are homogenous assays for direct determination. DiaSys has also expanded the application range for its Total bile acids 21 FS reagent and now offers the assay for use in serum and stool samples. DiaSys Total bile acids 21 FS for serum and stool samples may be conveniently applied on automated analyzers commonly available in any clinical laboratory and are highly time-saving.

Related Links:
DiaSys Diagnostic Systems 


New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Automated Blood Typing System
IH-500 NEXT
New
Sulfidoleukotrienes (sLT) Assay
CAST ELISA
New
Auto-Chemistry Analyzer
CS-1200

Latest AACC 2023 News

First-of-Its-Kind Single-Cell Clinical Microbiology Platform Wins 2023 Disruptive Technology Award

Ground-Breaking Phage-Based Diagnostic Kit for Laboratory Tuberculosis Testing Presented at AACC 2023

Laboratory Experts Show How They Are Leading the Way on Global Trends